| Laboratory detection of Enterobacteriaceae that produce carbapenemases D Doyle, G Peirano, C Lascols, T Lloyd, DL Church, JDD Pitout Journal of clinical microbiology 50 (12), 3877-3880, 2012 | 458 | 2012 |
| Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America C Lascols, G Peirano, M Hackel, KB Laupland, JDD Pitout Antimicrobial agents and chemotherapy 57 (1), 130-136, 2013 | 233 | 2013 |
| Increasing prevalence and dissemination of NDM-1 metallo-β-lactamase in India: data from the SMART study (2009) C Lascols, M Hackel, SH Marshall, AM Hujer, S Bouchillon, R Badal, ... Journal of antimicrobial chemotherapy 66 (9), 1992-1997, 2011 | 220 | 2011 |
| Evaluation of a New Test, GenoType HelicoDR, for Molecular Detection of Antibiotic Resistance in Helicobacter pylori E Cambau, V Allerheiligen, C Coulon, C Corbel, C Lascols, L Deforges, ... Journal of Clinical Microbiology 47 (11), 3600-3607, 2009 | 204 | 2009 |
| Single and Double Mutations in gyrA but Not in gyrB Are Associated with Low- and High-Level Fluoroquinolone Resistance in Helicobacter pylori J Tankovic, C Lascols, Q Sculo, JC Petit, CJ Soussy Antimicrobial agents and chemotherapy 47 (12), 3942-3944, 2003 | 180 | 2003 |
| Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations M Hackel, C Lascols, S Bouchillon, B Hilton, D Morgenstern, J Purdy Vaccine 31 (42), 4881-4887, 2013 | 163 | 2013 |
| Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility V Cattoir, J Nectoux, C Lascols, L Deforges, JC Delchier, F Megraud, ... International journal of antimicrobial agents 29 (4), 389-396, 2007 | 158 | 2007 |
| Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase–producing species, in urinary tract isolates from … DJ Hoban, C Lascols, LE Nicolle, R Badal, S Bouchillon, M Hackel, ... Diagnostic microbiology and infectious disease 74 (1), 62-67, 2012 | 157 | 2012 |
| Single or Double Mutational Alterations of GyrA Associated with Fluoroquinolone Resistance in Campylobacter jejuni and Campylobacter coli R Bachoual, S Ouabdesselam, F Mory, C Lascols, CJ Soussy, J Tankovic Microbial drug resistance 7 (3), 257-261, 2001 | 136 | 2001 |
| Fast and Accurate Quantitative Detection of Helicobacter pylori and Identification of Clarithromycin Resistance Mutations in H. pylori Isolates from Gastric Biopsy … C Lascols, D Lamarque, JM Costa, C Copie-Bergman, JM Le Glaunec, ... Journal of clinical microbiology 41 (10), 4573-4577, 2003 | 128 | 2003 |
| Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli E Cambau, S Matrat, XS Pan, R Roth Dit Bettoni, C Corbel, A Aubry, ... Journal of Antimicrobial Chemotherapy 63 (3), 443-450, 2009 | 106 | 2009 |
| Occurrence of qnrA-positive clinical isolates in French teaching hospitals during 2002–2005 E Cambau, C Lascols, W Sougakoff, C Bebear, R Bonnet, JD Cavallo, ... Clinical microbiology and infection 12 (10), 1013-1020, 2006 | 96 | 2006 |
| Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases: a snapshot of extended-spectrum β-lactamases throughout the world C Lascols, M Hackel, AM Hujer, SH Marshall, SK Bouchillon, DJ Hoban, ... Journal of clinical microbiology 50 (5), 1632-1639, 2012 | 87 | 2012 |
| Susceptibility of Klebsiella pneumoniae Isolates from Intra-Abdominal Infections and Molecular Characterization of Ertapenem-Resistant Isolates SP Hawser, SK Bouchillon, C Lascols, M Hackel, DJ Hoban, RE Badal, ... Antimicrobial agents and chemotherapy 55 (8), 3917-3921, 2011 | 87 | 2011 |
| Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular … SP Hawser, SK Bouchillon, C Lascols, M Hackel, DJ Hoban, RE Badal, ... Clinical Microbiology and Infection 18 (3), 253-259, 2012 | 83 | 2012 |
| Impact of Helicobacter pylori resistance to clarithromycin on the efficacy of the omeprazole–amoxicillin–clarithromycin therapy J Tankovic, D Lamarque, C Lascols, CJ Soussy, JC Delchier Alimentary pharmacology & therapeutics 15 (5), 707-713, 2001 | 83 | 2001 |
| Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes A Cesaro, RRD Bettoni, C Lascols, A Mérens, CJ Soussy, E Cambau Journal of antimicrobial chemotherapy 61 (5), 1007-1015, 2008 | 80 | 2008 |
| The Pentapeptide Repeat Proteins MfpAMt and QnrB4 Exhibit Opposite Effects on DNA Gyrase Catalytic Reactions and on the Ternary Gyrase-DNA-Quinolone … A Mérens, S Matrat, A Aubry, C Lascols, V Jarlier, CJ Soussy, JD Cavallo, ... Journal of bacteriology 191 (5), 1587-1594, 2009 | 72 | 2009 |
| Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates S Lomonaco, MA Crawford, C Lascols, RE Timme, K Anderson, ... PLoS One 13 (6), e0198526, 2018 | 65 | 2018 |
| Molecular epidemiology of Enterobacteriaceae that produce VIMs and IMPs from the SMART surveillance program G Peirano, C Lascols, M Hackel, DJ Hoban, JDD Pitout Diagnostic microbiology and infectious disease 78 (3), 277-281, 2014 | 61 | 2014 |
